Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116921265 | 11692126 | 5 | F | 2011 | 20160728 | 20151103 | 20160805 | EXP | CA-AMGEN-CANSP2015114671 | AMGEN | 51.00 | YR | A | F | Y | 63.00000 | KG | 20160805 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116921265 | 11692126 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
| 116921265 | 11692126 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 116921265 | 11692126 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 25 MG, UNK | 0 | 25 | MG | ||||||||
| 116921265 | 11692126 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 2.5 MG, 8 TABLETS ONCE A WEEK X 2 | 0 | 2.5 | MG | ||||||||
| 116921265 | 11692126 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 15 MG, QWK | 0 | 15 | MG | /wk | |||||||
| 116921265 | 11692126 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 116921265 | 11692126 | 7 | C | VIMOVO | ESOMEPRAZOLE MAGNESIUMNAPROXEN | 1 | 500-20 MG TABLET 1 TABLET(S) TWO TIMES DAILY | 0 | TABLET | BID | |||||||||
| 116921265 | 11692126 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, QWK | 0 | 5 | MG | /wk | ||||||||
| 116921265 | 11692126 | 9 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 500 MG, BID | 0 | 500 | MG | BID | |||||||
| 116921265 | 11692126 | 10 | C | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 116921265 | 11692126 | 11 | C | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 40 MG, QWK | 0 | 40 | MG | /wk | |||||||
| 116921265 | 11692126 | 12 | C | ACTEMRA | TOCILIZUMAB | 1 | UNK | 0 | |||||||||||
| 116921265 | 11692126 | 13 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | Intra-articular | 80 MG, UNK | 0 | 80 | MG | INJECTION | |||||||
| 116921265 | 11692126 | 14 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, BID | 0 | 150 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116921265 | 11692126 | 1 | Rheumatoid arthritis |
| 116921265 | 11692126 | 2 | Rheumatoid arthritis |
| 116921265 | 11692126 | 3 | Rheumatoid arthritis |
| 116921265 | 11692126 | 9 | Arthralgia |
| 116921265 | 11692126 | 13 | Rheumatoid arthritis |
| 116921265 | 11692126 | 14 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116921265 | 11692126 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116921265 | 11692126 | Abdominal pain | |
| 116921265 | 11692126 | Activities of daily living impaired | |
| 116921265 | 11692126 | Arthralgia | |
| 116921265 | 11692126 | Chest pain | |
| 116921265 | 11692126 | Condition aggravated | |
| 116921265 | 11692126 | Drug ineffective | |
| 116921265 | 11692126 | Dry eye | |
| 116921265 | 11692126 | Dyspnoea | |
| 116921265 | 11692126 | Eye irritation | |
| 116921265 | 11692126 | Eye pain | |
| 116921265 | 11692126 | Fatigue | |
| 116921265 | 11692126 | Fibromyalgia | |
| 116921265 | 11692126 | Gait disturbance | |
| 116921265 | 11692126 | Infection | |
| 116921265 | 11692126 | Interstitial lung disease | |
| 116921265 | 11692126 | Joint crepitation | |
| 116921265 | 11692126 | Joint swelling | |
| 116921265 | 11692126 | Lung disorder | |
| 116921265 | 11692126 | Mass | |
| 116921265 | 11692126 | Maternal exposure during pregnancy | |
| 116921265 | 11692126 | Mobility decreased | |
| 116921265 | 11692126 | Musculoskeletal pain | |
| 116921265 | 11692126 | Musculoskeletal stiffness | |
| 116921265 | 11692126 | Nausea | |
| 116921265 | 11692126 | Nervousness | |
| 116921265 | 11692126 | Nodule | |
| 116921265 | 11692126 | Ocular hyperaemia | |
| 116921265 | 11692126 | Osteoarthritis | |
| 116921265 | 11692126 | Pain | |
| 116921265 | 11692126 | Pain in extremity | |
| 116921265 | 11692126 | Photophobia | |
| 116921265 | 11692126 | Pleuritic pain | |
| 116921265 | 11692126 | Rheumatoid arthritis | |
| 116921265 | 11692126 | Swelling | |
| 116921265 | 11692126 | Synovial cyst | |
| 116921265 | 11692126 | Tenosynovitis stenosans |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116921265 | 11692126 | 1 | 200812 | 201007 | 0 | |
| 116921265 | 11692126 | 3 | 2008 | 0 | ||
| 116921265 | 11692126 | 4 | 201409 | 0 | ||
| 116921265 | 11692126 | 6 | 2014 | 0 | ||
| 116921265 | 11692126 | 7 | 20140911 | 0 | ||
| 116921265 | 11692126 | 8 | 20140911 | 0 | ||
| 116921265 | 11692126 | 11 | 201008 | 201312 | 0 | |
| 116921265 | 11692126 | 12 | 2014 | 0 |